Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Camici (2008)
From microcirculation to cardiac event: protection with Preterax.Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 26 2
A. Feldman, E. Weinberg, P. Ray, B. Lorell (1993)
Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding.Circulation research, 73 1
S. Silver (1937)
Heart FailureThe Indian Medical Gazette, 72
K. Rajappan, O. Rimoldi, D. Dutka, B. Ariff, D. Pennell, D. Sheridan, P. Camici (2002)
Mechanisms of Coronary Microcirculatory Dysfunction in Patients With Aortic Stenosis and Angiographically Normal Coronary ArteriesCirculation: Journal of the American Heart Association, 105
Jouni Uitto, David Kouba (2000)
Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases.Journal of dermatological science, 24 Suppl 1
B. Zhao, Wen Jiang, Y. Zhao, J. Hou, W. Xin (1996)
Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury.Biochemistry and molecular biology international, 38 6
A. Shiozaki, Tiago Senra, E. Arteaga, C. Pita, M. Filho, L. Ávila, J. Filho, C. Mady, C. Rochitte (2010)
[Myocardial fibrosis in patients with hypertrophic cardiomyopathy and high risk for sudden death].Arquivos brasileiros de cardiologia, 94 4
Celine Weiss, Marco Hagenmüller, M. Pichler, Sebastian Münz, M. Ochs, S. Buss, R. Bekeredjian, H. Katus, S. Hardt (2010)
Activation of PPARγ by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 381
F. Krötz, H. Sohn, U. Pohl (2004)
Reactive Oxygen Species: Players in the Platelet GameArteriosclerosis, Thrombosis, and Vascular Biology, 24
Jing‐Yan Han, Y. Horie, Jing-yu Fan, Kai Sun, Jun Guo, S. Miura, T. Hibi (2009)
Potential of 3,4-dihydroxy-phenyl lactic acid for ameliorating ischemia-reperfusion-induced microvascular disturbance in rat mesentery.American journal of physiology. Gastrointestinal and liver physiology, 296 1
José Garcia, E. Incerpi (2008)
Factors and mechanisms involved in left ventricular hypertrophy and the anti-hypertrophic role of nitric oxide.Arquivos brasileiros de cardiologia, 90 6
(2008)
T
Na Zhao, Yu-ying Liu, Fang Wang, Bai-he Hu, Kai Sun, Xin Chang, C. Pan, Jing-yu Fan, Xiao‐Hong Wei, Xiang Li, Chuan‐She Wang, Zhixin Guo, Jing‐Yan Han (2010)
Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats.American journal of physiology. Heart and circulatory physiology, 298 4
(2010)
Cardiotonic pills
Ding Ai, W. Pang, Nan Li, Ming-Jiang Xu, Paul Jones, Jun Yang, You-yi Zhang, N. Chiamvimonvat, J. Shyy, B. Hammock, Yi Zhu (2009)
Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophyProceedings of the National Academy of Sciences, 106
(2007)
Effect of Rosewood and Integripetal rhodiola herb on collagen ratio of myocardial infarction of rats
Ying Xia, Keunsang Lee, Na Li, Dan Corbett, L. Mendoza, N. Frangogiannis (2009)
Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overloadHistochemistry and Cell Biology, 131
(2007)
Tanshinone IIB
Peng Zhao, G. Su, Xiaoyan Xiao, Enkui Hao, Xinglei Zhu, Jun Ren (2008)
Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis.Toxicology letters, 182 1-3
P. Knaapen, T. Germans, P. Camici, O. Rimoldi, F. Cate, J. Berg, P. Dijkmans, R. Boellaard, W. Dockum, M. Götte, J. Twisk, A. Rossum, A. Lammertsma, F. Visser (2008)
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.American journal of physiology. Heart and circulatory physiology, 294 2
Guolong Yu, Xiaoqiu Liang, Xiumei Xie, Tianlun Yang, Ming Sun, Shuiping Zhao (2002)
Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.Chinese medical journal, 115 9
Yue-ke Zhu, Z. Duan, Bao-en Wang (2007)
[Experimental study of Qishen Yiqi Dropping Pills on liver fibrosis in rats].Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 27 3
P. Pacher, R. Schulz, L. Liaudet, C. Szabó (2005)
Nitrosative stress and pharmacological modulation of heart failure.Trends in pharmacological sciences, 26 6
M. Rodriguez-Porcel, Xiang-yang Zhu, A. Chade, B. Amores-Arriaga, N. Caplice, E. Ritman, A. Lerman, L. Lerman (2006)
Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension.American journal of physiology. Heart and circulatory physiology, 290 3
Xi-yong Yu, Shu-guang Lin, Zhi-Wei Zhou, Xiao Chen, Jun Liang, W. Duan, Xue-Qing Yu, J. Wen, B. Chowbay, Chunguang Li, F. Sheu, E. Chan, Shufeng Zhou (2007)
Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked ratsNeuroscience Letters, 417
M. Trojanowska, Leroy Ec, B. Eckes, T. Krieg (1998)
Pathogenesis of fibrosis: type 1 collagen and the skinJournal of Molecular Medicine, 76
Yun-Lian Lin, Chia‐Hung Wu, M. Luo, Yeh‐Jeng Huang, Chuen‐Neu Wang, M. Shiao, Yi‐Tsau Huang (2006)
In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells.Journal of ethnopharmacology, 105 1-2
D. Lévy, R. Garrison, D. Savage, W. Kannel, W. Castelli (1990)
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.The New England journal of medicine, 322 22
(2009)
Protections of SMND-309
Chengtao Hong, Yi Wang, Jian-Tao Lou, Qiang Liu, Hai-bin Qu, Yiyu Cheng (2009)
[Analysis of myocardial proteomic alteration after Qishenyiqi formula treatment in acute infarcted rat hearts].Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 34 8
D. Sorescu, K. Griendling (2002)
Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.Congestive heart failure, 8 3
(2002)
Apoptosis
P. Biagi, Luigi Abate (2005)
Heart failure, oxidative stress and allopurinol.Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 64 1
(2009)
S
P. Voziyan, Eugenia Yazlovitskaya (2014)
Reactive Oxygen SpeciesJournal of Bioequivalence & Bioavailability, 2014
Jiying Yang, Kai Sun, Chuan‐She Wang, Jun Guo, Xin Xue, Yu-ying Liu, Jun Zheng, Jing-yu Fan, F. Liao, Jing‐Yan Han (2008)
Improving effect of post-treatment with Panax notoginseng saponins on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery.Clinical hemorheology and microcirculation, 40 2
Jingwei Tian, F. Fu, Gui-sheng Li, Yubai Gao, Yunjuan Zhang, Q. Meng, Chang-Kun Li, Fu Liu (2009)
Protections of SMND-309, a novel derivate of salvianolic acid B, on brain mitochondria contribute to injury amelioration in cerebral ischemia rats.Phytomedicine : international journal of phytotherapy and phytopharmacology, 16 8
C. Waller, K. Hiller, E. Kahler, K. Hu, M. Nahrendorf, S. Voll, A. Haase, G. Ertl, W. Bauer (2001)
Serial Magnetic Resonance Imaging of Microvascular Remodeling in the Infarcted Rat HeartCirculation: Journal of the American Heart Association, 103
QiShen YiQi Pills ® (QSYQ) is a compound Chinese medicine used for treatment of cardiovascular diseases. However, the potential of QSYQ to inhibit cardiac fibrosis in left ventricle hypertrophy is not explored to date. We investigated the effects of post-treatment with QSYQ on rat myocardial fibrosis in left ventricle hypertrophy induced by pressure over-load through ascending aortic stenosis. QSYQ was administrated 4 weeks after the surgery, at a dose of 0.8 g/kg/day over the next 4 weeks, while echocardiography was performed 4 and 8 weeks, respectively, after the surgery. Eight weeks after the surgery, myocardial blood flow was determined by Laser-Doppler Perfusion Imager and the ratio of heart weight to body weight (HW/BW) was estimated, in concurrent evaluation of myocardial histology and ultrastructure, as well as collagen content by sirius red staining, and immunohistochemistry staining for CD68 and transforming growth factor beta 1. Post-treatment with QSYQ significantly alleviated left ventricular posterior wall end diastolic thickness and the HW/BW, increased left ventricle ejection fraction and left ventricle fractional shortening. QSYQ also decreased myocardial fibrosis size. The expression of CD68 and transforming growth factor beta 1 were obviously suppressed after QSYQ treatment. The results suggest that post-treatment with QSYQ attenuates pressure over-load-induced cardiac hypertrophy and myocardial fibrosis through interfering in inflammatory process.
Clinical Hemorheology and Microcirculation – IOS Press
Published: Jan 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.